Processing

Please wait...

Settings

Settings

Goto Application

1. EP2388012 - Kisspeptin peptides for use in the treatment of Alzheimer's disease, Creutzfeldt-Jakob disease or diabetes mellitus

EP2388012Kisspeptin peptides for use in the treatment of Alzheimer's disease, Creutzfeldt-Jakob disease or diabetes mellitus
Appl.Date 20.05.2010
Appl.No 10163479 Applicant ROEHAMPTON UNIVERSITY Pub.Kind A1 Pub.Lang en
Inclusion Criteria IC5
Sole priority inside the family.
Pub.Date 23.11.2011
GB2493313Kissorphin peptides for use in the treatment of alzheimer's disease, creutzfeldt-jakob disease or diabetes mellitus
Appl.Date 19.05.2011
Appl.No 201220630 Applicant ROEHAMPTON UNIV Pub.Kind A,D0,B Pub.Lang en
Inclusion Criteria IC6
Connected by priority field.
Pub.Date 02.01.2013
WO/2011/144714KISSORPHIN PEPTIDES FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE, CREUTZFELDT- JAKOB DISEASE OR DIABETES MELLITUS
Appl.Date 19.05.2011
Appl.No PCT/EP2011/058213 Applicant MILTON, Nathaniel Pub.Kind A Pub.Lang en
Inclusion Criteria IC1
PCT application from which the family originated.
Pub.Date 24.11.2011